IL116745A - Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treating hyperlipoproteinaemia and hypercholesterolaemia - Google Patents

Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treating hyperlipoproteinaemia and hypercholesterolaemia

Info

Publication number
IL116745A
IL116745A IL11674596A IL11674596A IL116745A IL 116745 A IL116745 A IL 116745A IL 11674596 A IL11674596 A IL 11674596A IL 11674596 A IL11674596 A IL 11674596A IL 116745 A IL116745 A IL 116745A
Authority
IL
Israel
Prior art keywords
hypercholesterolaemia
preparation
pharmaceutical compositions
hyperlipoproteinaemia
treating
Prior art date
Application number
IL11674596A
Other versions
IL116745A0 (en
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL116745A0 publication Critical patent/IL116745A0/en
Publication of IL116745A publication Critical patent/IL116745A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11674596A 1995-01-13 1996-01-12 Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treating hyperlipoproteinaemia and hypercholesterolaemia IL116745A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DK4195 1995-01-13
DK4395 1995-01-13
DK6995 1995-01-20
DK76695 1995-06-30
DK76795 1995-06-30
DK77795 1995-06-30

Publications (2)

Publication Number Publication Date
IL116745A0 IL116745A0 (en) 1996-05-14
IL116745A true IL116745A (en) 1999-12-22

Family

ID=27545138

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11674596A IL116745A (en) 1995-01-13 1996-01-12 Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treating hyperlipoproteinaemia and hypercholesterolaemia

Country Status (11)

Country Link
EP (1) EP0804189A1 (en)
JP (1) JPH10511961A (en)
CN (1) CN1168098A (en)
AU (1) AU4329296A (en)
BR (1) BR9606890A (en)
CA (1) CA2208859A1 (en)
CZ (1) CZ212397A3 (en)
HU (1) HUP9800521A3 (en)
IL (1) IL116745A (en)
NO (1) NO973241D0 (en)
WO (1) WO1996021443A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease
US6069175A (en) * 1996-11-15 2000-05-30 Pfizer Inc. Estrogen agonist/antagonists treatment of atherosclerosis
WO1999048497A1 (en) * 1998-03-20 1999-09-30 Novo Nordisk A/S USE OF 3,4-DIPHENYLCHROMANS FOR THE MANUFACTURE OF A PHARMACEUTICAL COMPOSITION FOR LOWERING PLASMA LEVELS OF Lp(a) IN A HUMAN OR SUB-HUMAN PRIMATE
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
EP1794141B1 (en) 2004-09-21 2011-11-09 Marshall Edwards, Inc. Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
US9663484B2 (en) 2010-11-01 2017-05-30 Mei Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
CN108484559A (en) 2014-02-07 2018-09-04 凯捷治疗有限公司 Functionalized benzopyran compounds and application thereof
CN116139125A (en) 2015-02-02 2023-05-23 梅制药公司 Combination therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1543749A1 (en) * 1966-02-16 1969-12-11 Merck Ag E Process for the preparation of 3,4-cis-4-aryl-isoflavans
US5407955A (en) * 1994-02-18 1995-04-18 Eli Lilly And Company Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

Also Published As

Publication number Publication date
WO1996021443A1 (en) 1996-07-18
IL116745A0 (en) 1996-05-14
HUP9800521A2 (en) 1998-12-28
CZ212397A3 (en) 1997-11-12
NO973241L (en) 1997-07-11
CN1168098A (en) 1997-12-17
HUP9800521A3 (en) 1999-12-28
CA2208859A1 (en) 1996-07-18
JPH10511961A (en) 1998-11-17
AU4329296A (en) 1996-07-31
BR9606890A (en) 1997-10-28
NO973241D0 (en) 1997-07-11
EP0804189A1 (en) 1997-11-05
MX9705214A (en) 1997-10-31

Similar Documents

Publication Publication Date Title
GR3035410T3 (en) Benzazepin-, benzoxazepin- and benzothiazepin-N-acetic acid-derivatives, their preparation and their pharmaceutical compositions
GR3032316T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
IL124994A0 (en) Taxoids preparation thereof and pharmaceutical compositions containing same
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
EP0852233A4 (en) Cyclosporin phosphate derivatives and medicinal composition
IL117878A0 (en) Taxoids, their preparation and pharmaceutical compositions containing them
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
IL116745A (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions for treating hyperlipoproteinaemia and hypercholesterolaemia
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
HUP9901434A3 (en) Substituted benzylamines and their use for the preparation of medicaments for treating depression
IL117397A (en) Substituted naphthyl compounds and pharmaceutical compositions comprising them
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
GR3036410T3 (en) Taxoids, their preparation and pharmaceutical compositions containing them
HUP9802042A3 (en) Taxoids, preparation thereof, and pharmaceutical compositions containing same
IL116826A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and methods of use thereof
IL117806A0 (en) 1,3-Dihydro-2h-imidazol-2-one derivatives their preparation and pharmaceutical compositions containing them
HU9603388D0 (en) New taxoids, preparation thereof and pharmaceutical compositions containing them
IL124415A (en) N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them
IL119603A (en) Amidinohydrazone derivatives methods for the preparation thereof and pharmaceutical compositions containing the same
IL116747A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116827A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
GR3036411T3 (en) Novel taxoids, preparation thereof and pharmaceutical compositions containing same
IL120469A0 (en) 1, 25-dihydroxy-16,22,23-trisdehydro-cholecalciferol derivatives their preparation and pharmaceutical compositions containing them
AU3081595A (en) Taxoids, preparation thereof and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees